Albaad (ALBA) AI Stock Analysis

• Market Cap: 362.88M
• Dividend Yield: N/A
• Average Volume (3M): 12.76K
• Price to Earnings (P/E): 8.7
• Beta (1Y): 0.34
• Revenue Growth: N/A
• EPS Growth: N/A
• Country: IL
• Employees: 1,670
• Sector: Consumer Defensive
• Sector Strength: 66
• Industry: Household & Personal Products
• EPS (TTM): 2.41
• Shares Outstanding: 18,647,507
• 10 Day Avg. Volume: 8,468
• 30 Day Avg. Volume: 12,755
• PEG Ratio: -0.27
• Price to Book (P/B): 0.41
• Price to Sales (P/S): 0.00
• P/FCF Ratio: -2.12
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 72 Outperform
• Price Target: 2,220.00 ▲(4.67%Upside)

Albaad's stock shows strong technical momentum and reasonable valuation, which are its primary strengths. Financial performance is positive but hindered by high leverage. The lack of earnings call and corporate events data means these factors did not influence the score.

Albaad Business Overview & Revenue Model

Company Description

Albaad (ALBA) is a leading manufacturer in the global hygiene and personal care industry, specializing in the production of wet wipes, feminine hygiene products, and other nonwoven fabric-based goods. The company operates across various sectors, including consumer, health care, and industrial markets, providing high-quality private label solutions to well-known retailers and brands worldwide.

How the Company Makes Money

Albaad generates revenue through the manufacturing and sale of private label wet wipes, feminine hygiene products, and other nonwoven fabric items. The company's key revenue streams include contracts with major retailers and brands who seek customized hygiene solutions. Additionally, Albaad capitalizes on its global manufacturing footprint and innovative product development to maintain competitive pricing and attract a diverse client base. The company's earnings are further bolstered by strategic partnerships and investments in R&D, allowing for the introduction of new products that meet evolving consumer demands.

Albaad Financial Statement Overview

Summary

Albaad has shown improvements in profitability with stronger gross and net profit margins and enhanced operational efficiency. However, the high debt-to-equity ratio of 1.67 poses a risk, necessitating careful management to maintain financial health.

Income Statement

Albaad has shown notable improvement in profitability metrics over the years. The gross profit margin and net profit margin have seen upticks, with a gross profit margin of approximately 20.2% for 2024 and a net profit margin of 2.6%. Revenue growth has been volatile, with a slight increase of 0.5% from 2023 to 2024, following larger fluctuations in prior years. The EBIT and EBITDA margins have strengthened in 2024, indicating improved operational efficiency.

Balance Sheet

The balance sheet reveals a high debt-to-equity ratio of 1.67, indicating significant leverage, which could pose a risk if not managed carefully. The equity ratio stands at 28.3%, suggesting a moderate level of equity in the capital structure. Return on equity has improved to 10.5% in 2024, reflecting better profitability relative to shareholders' equity.

Cash Flow

Cash flow from operations has been strong, with an operating cash flow to net income ratio of 3.4 in 2024, showcasing robust cash generation. Free cash flow has grown, with a 2024 free cash flow to net income ratio of 2.3, indicating effective cash management despite capital expenditures. Free cash flow growth from 2023 to 2024 was negative at -16%, suggesting some volatility in cash flow management.

Breakdown
Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement		Total Revenue
1.72B	1.71B	1.45B	1.49B	1.58B
	Gross Profit
347.93M	344.37M	235.00M	270.70M	418.70M
	EBIT
107.06M	93.04M	-1.17M	28.07M	174.35M
	EBITDA
192.42M	176.03M	91.96M	192.56M	281.40M
	Net Income Common Stockholders
44.88M	30.23M	-35.12M	-20.34M	101.31M
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
25.16M	19.13M	27.19M	18.24M	34.05M
	Total Assets
1.51B	1.58B	1.60B	1.57B	1.41B
	Total Debt
712.92M	829.03M	836.53M	802.11M	609.00M
	Net Debt
687.76M	809.90M	809.35M	783.87M	574.95M
	Total Liabilities
1.07B	1.18B	1.24B	1.14B	927.61M
	Stockholders Equity
426.68M	394.08M	346.83M	430.25M	478.58M
Cash Flow		Free Cash Flow
101.60M	120.98M	-67.58M	-38.08M	114.28M
	Operating Cash Flow
152.50M	233.23M	18.57M	52.58M	184.72M
	Investing Cash Flow
-9.51M	-110.94M	-30.36M	-170.24M	-22.61M
	Financing Cash Flow
-135.56M	-134.49M	20.46M	103.68M	-149.09M

Albaad Technical Analysis

• Technical Analysis Sentiment: Neutral
• Last Price: 2121.00
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IL:ALBA, the sentiment is Neutral. The current price of 2121 is above the 20-day moving average (MA) of 1986.65, above the 50-day MA of 1853.14, and above the 200-day MA of 1805.91, indicating a neutral trend. The MACD of 24.11 indicates Positive momentum. The RSI at 49.31 is Neutral, neither overbought nor oversold. The STOCH value of 33.12 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for IL:ALBA.

Albaad Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
STRS	82 Outperform	10.80B	16.39	21.74%	3.33%	6.49%	113.90%
Sector *	74 Outperform	3.08B	22.21	12.30%	5.86%	8.41%	43.90%
ALBA	72 Outperform	362.88M	8.71		―	―	―
ICL	70 Neutral	$8.67B	22.29	6.70%	2.56%	-3.48%	-18.34%
TSEM	64 Neutral	$4.41B	21.86	7.88%	―	5.22%	-58.99%
ELCO	63 Neutral	4.92B	―		6.85%	11.27%	79.98%

Albaad Corporate Events

Albaad’s Securities Offering Period Extended to 2025

Albaad, a company with securities listed on the Tel Aviv Stock Exchange, has announced that the Securities Authority has extended the validity period for offering securities according to its shelf prospectus until November 6, 2025. This extension is expected to impact Albaad’s operational strategy by providing more time for financial maneuvering and potentially improving its market positioning, assuring stakeholders of continued investment opportunities.